Trades on 2 secondary markets

Numerion Labs

Atomwise pioneered the use of deep convolutional neural networks for structure-based drug discovery, with its AtomNet platform applying AI to virtual screening of small molecules against protein targets. The company ran the Artificial Intelligence Molecular Screen (AIMS) academic collaboration progr

minimal 7.4 / 100 0 APIs View provider profile →

Drug Discovery Biotech Pharmaceuticals Structure-Based Drug Design Virtual Screening Deep Learning

Numerion Labs is an API provider whose private shares are listed on 2 secondary markets: Forge Global, EquityZen.

Where It Trades

F Forge Global View listing → EZ EquityZen View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.